Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAPATINIB DITOSYLATE vs LARONIDASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAPATINIB DITOSYLATE vs LARONIDASE: Safety Overview

Metric LAPATINIB DITOSYLATE LARONIDASE
Total FAERS Reports 3,948 3,089
Deaths Reported 921 430
Death Rate 23.3% 13.9%
Hospitalizations 752 987
Average Patient Age 57.3 yrs 14.7 yrs
% Female Patients 95.0% 50.5%
FDA Approval Date Aug 16, 2024 N/A
Manufacturer AvKARE Genzyme Corporation
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription